marketinsider

Calling All EVLV Investors: Let’s Take Charge of the Evolv Technologies Securities Fraud Lawsuit with The Schall Law Firm!

Welcome to the Wild World of Wall Street Lawsuits! What’s the Deal with Evolv Technologies Holdings, Inc.? So, it looks like Evolv Technologies Holdings, Inc. is in a bit of hot water with investors. The Schall Law Firm is reminding everyone about a class action lawsuit against the company for allegedly violating some Securities Exchange…

Read More

Is Microsoft Ready to Make a $100 Billion Bet on Bitcoin? Here’s What Could Make It Happen

Big Tech Embracing Bitcoin: Microsoft Considers Investing in Cryptocurrency The Rise of Bitcoin in the Tech Industry As Bitcoin continues to play hide-and-seek with its major $100,000 valuation, tech giant Microsoft is all set to vote on investing in it, according to a filing with the US Securities and Exchange Commission (SEC). The largest cryptocurrency…

Read More

LeddarTech Gets Creative: Credit Facility and Bridge Financing Offer Updated for 2024!

LeddarTech Gets Creative: Credit Facility and Bridge Financing Offer Updated for 2024! Introduction QUEBEC CITY, Canada, Dec. 09, 2024 (GLOBE NEWSWIRE) — LeddarTech ® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology, LeddarVision™, today announced that LeddarTech and Texas Instruments (“TI”) have…

Read More

Unleashing the Power of AI: A Look into Salesforce’s Recent Earnings and the Future of Technology

Salesforce’s Fiscal Q3 Earnings: A Quirky Rollercoaster Ride When Numbers Paint a Colorful Picture It was a wild ride for Salesforce (CRM) as they unveiled their fiscal Q3 earnings on Tuesday. The results were a mixed bag of surprises that left investors buzzing with excitement. Despite falling slightly short of analyst estimates on earnings, Salesforce…

Read More

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients MANNHEIM, Germany, Dec. 08, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) Affimed, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the presentation of data in a…

Read More

Possible Fraud at Applied Therapeutics Inc: Levi & Korsinsky Investigates Shareholders’ Claims

Levi & Korsinsky Investigates Applied Therapeutics, Inc. for Securities Violations New York, NY / ACCESSWIRE / December 8, 2024 Levi & Korsinsky, a leading securities litigation firm, has announced that it is conducting an investigation into Applied Therapeutics, Inc. (NASDAQ:APLT) for potential violations of federal securities laws. The investigation comes in response to a press…

Read More

Customers Bancorp Inc. Faces Lawsuit for Securities Violations: The Schall Law Firm Urges Stockholders to Take Action

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Customers Bancorp, Inc. Overview of the Lawsuit The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of a class action lawsuit against Customers Bancorp, Inc. (“Customers Bancorp” or “the Company”) (NYSE:CUBI) for violations of 10(b) and 20(a) of the Securities…

Read More